Hereditary hemochromatosis: Presenting manifestations and diagnostic delay;Hémochromatose héréditaire: Circonstances de découverte et délais diagnostiques

Revue de Medecine Interne

Volumn 35, Issue 3, 2014, Pages 160-165

  Gasser, B ^a   Courtois, F ^b   Hojjat Assari, S ^c   Sauleau, E A ^d   Buffet, C ^e   Brissot, P ^f  

^a Service de pathologie HÔpital E Muller   (France)

^b EFAPH European Federation of Associations of Patients with Haemochromatosis   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e HÔpital Bicêtre   (France)

^f PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Arthropathy; C282Y homozygosity; Diagnostic delay; Hereditary hemochromatosis; Serum ferritin

Indexed keywords

ARTHROPATHIE; ARTHROPATHY; C282Y HOMOZYGOSITY; DÉLAI DIAGNOSTIQUE; DIAGNOSTIC DELAY; FERRITINÉMIE; HEREDITARY HEMOCHROMATOSIS; HÉMOCHROMATOSE HÉRÉDITAIRE; HOMOZYGOTIE C282Y; SERUM FERRITIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DELAYED DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRANCE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84894044870     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.02.041     Document Type: Article

References (19)

1. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., et al. A novel MHC class I-like gene is mutated in patient with hereditary haemochromatosis. Nat Genet 1996, 13:399-408.
2. EASL clinical practice guideline for HFE hemochromatosis. J Hepatol 2010, 53:3-22. European Association For The Study Of The Liver.
3. Jouanolle A.M., Fergelot P., Gandon G., Yaounq J., Le Gall J.Y., David V. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutation. Hum Genet 1997, 5-6:544-547.
4. Aguilar-Martinez P., Picot M.C., Becker F., Boulot P., Montoya F., Mares P., et al. Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol 2001, 114:914-916.
5. Allen K.J., Gurrin L.C., Constantine C.C., Osborne N.J., Delatycki M.B., Nicoll A.J., et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008, 358:221-230.
6. Adams P.C., Kertesz A.E., Valberg L.S. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991, 90:445-449.
7. McDonnel S.M., Preston B.L., Jewell S.A., Barton J.C., Edwards C.Q., Adams P.C., et al. A survey of 2851patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999, 106:619-624.
8. Haute Autorité de santé. Prise en charge de l'hémochromatose liée au gène HFE (hémochromatose de type 1). Argumentaire juillet 2005. http://www.has-sante.fr/.
9. Bacon B.R., Sadiq S.A. Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997, 92:784-789.
10. Brissot P., Ball S., Rofail D., Cannon H., Jin V.W. Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment. Transfusion 2011, 51:1331-1338.
11. Milder M.S., Cook J.D., Finch C.A. Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 1980, 59:34-49.
12. Haute Autorité de santé. Évaluation clinique et économique de dépistage de l'hémochromatose HFE1en 2004. http://www.has-sante.fr/.
13. Deugnier Y., Lainé F., Le Lan C., Bardou-Jacquet E., Jouanolle A.M., Brissot P. Hémochromatoses et autres surcharges hépatiques en fer. EMC Hépatologie 2011, [7-007-B-22]. 10.1016/S1155-1976(11)40364-8.
14. Deugnier Y., Bardou-Jacquet E., Lainé F., Gandon Y., Jouanolle A.M. Diagnostic d'une surcharge hépatique en fer. Rev Med Int 2012, 33(Suppl.1):S10-S14.
15. Loréal O., Bardou-Jacquet E., Jouanolle A.M., Gandon Y., Deugnier Y., Brissot P., et al. Métabolisme du fer et outils diagnostiques pour le clinicien. Rev Med Interne 2012, 33(Suppl.1):S3-S9.
16. Bacon B.R., Adams P.C., Kowdley K.V., Powell L.W., Tavill A.S. Diagnosis and management of hemochromatosis: 2011practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011, 54:328-343.
17. Guyader D., Jacquelinet C., Moirand R., Mendler M.H., Chaperon J., David D., et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998, 115:929-936.
18. Barton J.C., Barton J.C., Acton R.T., So J., Chan S., Adam P.C. Increased risk of death from iron-overload among 422treated probands with HFE Hemochromatosis and serum levels of ferritin greater than 1000μg/L at diagnosis. Clin Gastroenterol Hepatol 2012, 10:412-416.
19. Sahinbegovic E., Dallos T., Aigner E., Axmann R., Manger B., Englbrecht M., et al. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 2010, 62:3792-3798.